"2"^^ . . "1466-3995" . . "[0C59A697E7A7]" . "The Clinical Outcome of Patients with B-cell Lymphoproliferative Disease (B-LPD) Seems to Be Improved by the Success in Induction of Polymerase Chain Reaction (PCR) Negativity Achieved by High Dose Therapy with Autologous Stem Cell Transplantation" . "Trn\u011Bn\u00FD, Marek" . . . "RIV/00216208:11110/01:00110794" . "1" . . . . "11110" . "The Clinical Outcome of Patients with B-cell Lymphoproliferative Disease (B-LPD) Seems to Be Improved by the Success in Induction of Polymerase Chain Reaction (PCR) Negativity Achieved by High Dose Therapy with Autologous Stem Cell Transplantation"@en . "148;149" . . . . . "RIV/00216208:11110/01:00110794!RIV/2002/MSM/111102/N" . . . "Slav\u00ED\u010Dkov\u00E1, Alena" . "Clinical;Outcome;Patients;B-cell;Lymphoproliferative;Disease;B-LPD;Seems;Improved;Success;Induction;Polymerase;Chain;Reaction;Negativity;Achieved;Therapy;Autologous;Transplantation"@en . . . . "3"^^ . . "Z(MSM 111100004)" . . . . . "Suppl. 1" . . "0"^^ . "4"^^ . . . "0"^^ . . "675747" . . "The Clinical Outcome of Patients with B-cell Lymphoproliferative Disease (B-LPD) Seems to Be Improved by the Success in Induction of Polymerase Chain Reaction (PCR) Negativity Achieved by High Dose Therapy with Autologous Stem Cell Transplantation" . "Hematology Journal" . . . . "The comparison of clinical outcome of patients with B-cell lymphoproliferative disease according to their PCR status after the high dose therapy with autologous stem cell transplantation or rituximab therapy." . "\u010Cern\u00FD, Jan" . . "GB - Spojen\u00E9 kr\u00E1lovstv\u00ED Velk\u00E9 Brit\u00E1nie a Severn\u00EDho Irska" . . "The Clinical Outcome of Patients with B-cell Lymphoproliferative Disease (B-LPD) Seems to Be Improved by the Success in Induction of Polymerase Chain Reaction (PCR) Negativity Achieved by High Dose Therapy with Autologous Stem Cell Transplantation"@en . . "The comparison of clinical outcome of patients with B-cell lymphoproliferative disease according to their PCR status after the high dose therapy with autologous stem cell transplantation or rituximab therapy."@en . .